期刊文献+

食管癌放射治疗临床靶区勾画的相关研究 被引量:2

Research on clinical target volume delineation in radiotherapy of esophageal carcinoma
原文传递
导出
摘要 放疗靶区的界定是影响食管癌精确放射治疗疗效的重要因素。目前食管癌临床靶区(CTV)的勾画范围仍存在较多争议,尚无统一标准。研究提示病理特征、影像学手段及淋巴结转移规律等因素对食管癌CTV勾画可能有指导作用。新的勾画方式如个体化勾画CTV已成为目前的研究热点。 Target volume definition is one of the important factors in precise radiotherapy of esophageal carcinoma. However, there is considerable controversy about delineation of esophageal carcinoma clinical target volume (CTV), and no consistent standard. Recent researches show that pathological characteristics, imaging methods and lymph node metastasis pattern may have guiding functions for CTV delineation. Novel delineation technique such as individual design has been a research hotspot.
作者 袁晓丽 李涛
出处 《国际肿瘤学杂志》 CAS 2013年第10期751-754,共4页 Journal of International Oncology
关键词 食管肿瘤 放射疗法 临床靶区 Esophageal neoplasms Radiotherapy Clinical target volume
  • 相关文献

参考文献25

  • 1韩大力,于金明,贾慧,原银萍.放射治疗中食管癌临床靶区确认的争议与共识[J].中华肿瘤杂志,2012,34(1):73-76. 被引量:6
  • 2Gao XS, Qiao X, Wu F, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gas- troesophageal junction carcinoma. Int J Radiat Oncol Biol Phys, 2007, 67(2) : 389-396.
  • 3Song Y, Liang Y, Zang R, et al. Application of serial section method to determine the radiotherapy target volume for esophageal squamous carcinoma. Cell Biochem Biophys, 2013, 66(2) : 351-356.
  • 4Yentz S, Wang TD. Molecular imaging for guiding oneologic prognosis and therapy in esophageal adenocarcinoma. Hosp Pract (1995), 2011, 39(2): 97-106.
  • 5Yue J, Chen L, Cabrera AR, et al. Measuring tumor cell proliferation with ^18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study. J Nucl Med, 2010, 51 (4): 528- 534.
  • 6Nakai Y, Shinoura S, Ahluwalia A, et al. Molecular imaging of epi- dermal growth factor-receptor and survivin in vivo in porcine esophage- al and gastric mucasae using probe-based confocal laser-induced endo- microscopy: proof of concept. J Physiol Pharmacol, 2012, 63 ( 3 ) : 303 -307.
  • 7吴凤鹏,高献书,王雅棣,卢付河,董稚明,乔学英.食管癌原发肿瘤及亚临床灶MMP-2和Survivin基因表达的初步研究[J].中华放射肿瘤学杂志,2008,17(4):269-273. 被引量:4
  • 8于金明.功能影像检测食管癌放疗过程中再增殖和乏氧以及预测临床疗效研究[J].中国工程科学,2012,14(7):9-19. 被引量:3
  • 9Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of local- ly advanced esophageal cancer: long-term follow-up of a prospective randomized trim (RTOG 85-01 ). Radiation Therapy Oncology Group. JAMA, 1999, 281(17) : 1623-1627.
  • 10Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncolagy Group 94-05 ) phase Ⅲ trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol, 2002, 20(5) : 1167-1174.

二级参考文献106

共引文献58

同被引文献53

  • 1高献书,刘朝兴.食管癌放射治疗的现在及未来[J].中国医学前沿杂志(电子版),2012,4(5):39-43. 被引量:2
  • 2王旭广,陈哲.CT和MRI检查对食管癌术前TN分期的价值[J].肿瘤,2005,25(3):281-283. 被引量:26
  • 3Gerlinger M, Rowan A J, Horswell S, et al. Intratumor heteroge- neity and branched evolution revealed by multiregion sequencing [J]. N Engl J Med, 2012, 366(10) : 883-892.
  • 4International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording, and reporting photo beam therapy [ R ]. Bethesda, MD : Internional Commission on Radiation Units and Measurements, 1993.
  • 5International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photo beam therapy (Supplement to ICRU Report 50) [ R]. Bethesda, MD: International Commission on Radiation Units and Measure- ments, 1999.
  • 6Hou DL, Shi GF, Gao XS, et al. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma[ J]. Radiat Oncol, 2013, 8( 1 ) : 169-175.
  • 7Schreurs LM, Busz DM, Paardekooper GM, et al. Impact of 18- fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variabilit~c:PET/CT improves esophageal target def- inition[J]. Dis Esophagus, 2010, 23(6) : 493-501.
  • 8Hatt M, Visvikis D, Albarghach NM, et al. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology [ J ]. Eur J Nucl Med Mol Imaging, 2011, 38(7) : 1191-1202.
  • 9Han D, Yu J, Yu Y, et al. Comparison of(18) F-fluorothymidine and(18) F-fluorodeoxyglueose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carci- noma of thoracic esophagus [J]. Int J Radiat Oncol Biol Phys, 2010, 76(4) : 1235-1241.
  • 10Konski A, Doss M, Milestone B, et al. The integration of 18-fluo- ro-deoxyglucose positron emission tomography and endoscopic ul- trasound in the treatment-planning process for esophagealcarcinoma[J]. Int J Radlat Oncol Biol Phys, 2005, 61 (4) : 1123-1128.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部